Literature DB >> 32245457

Depletion of β-sitosterol and enrichment of quercetin and rutin in Cissus quadrangularis Linn fraction enhanced osteogenic but reduced osteoclastogenic marker expression.

Jetsada Ruangsuriya1,2, Suporn Charumanee3, Supat Jiranusornkul3, Panee Sirisa-Ard3, Busaban Sirithunyalug3, Jakkapan Sirithunyalug3, Thanawat Pattananandecha2,3, Chalermpong Saenjum4,5.   

Abstract

BACKGROUND: Cissus quadrangularis Linn. (CQ) has been used in Indian and Thai traditional medicine for healing bone fractures because of numerous active ingredients in CQ. It is still unclear which compounds are the active ingredients for bone formation.
METHODS: The molecular docking technique, the ethanolic extraction along with hexane fractionation, and an in vitro experiment with a human osteoblast cell line (MG-63) were used to narrow down the active compounds, to prepare the CQ extract, and to test biological activities, respectively.
RESULTS: The molecular docking technique revealed that quercetin and β-sitosterol had highest and lowest potential to bind to estrogen receptors, respectively. Compared to the crude ethanol extract (P1), the ethanolic fraction (P2) was enriched with rutin and quercetin at 65.36 ± 0.75 and 1.06 ± 0.12 mg/g, respectively. Alkaline phosphatase (ALP) activity was significantly enhanced in osteoblasts exposed to the P2 in both tested concentrations. The amount of hydroxyproline was slightly increased in the P1 treatment, while osteocalcin was inhibited. Moreover, the P2 significantly activated osteoprotegerin (OPG) and inhibited receptor activator of nuclear factor κ ligand (RANKL) expression.
CONCLUSIONS: Taken together, the enriched rutin and quercetin fraction of CQ triggered the molecules involved in bone formation and the molecules inhibiting bone resorption.

Entities:  

Keywords:  Cissus quadrangularis Linn; Ethanolic fractionation; Human osteoblast cell line; Osteoporosis

Year:  2020        PMID: 32245457     DOI: 10.1186/s12906-020-02892-w

Source DB:  PubMed          Journal:  BMC Complement Med Ther        ISSN: 2662-7671


  5 in total

1.  Local Wisdom and Diversity of Medicinal Plants in Cha Miang Forest in Mae Kampong Village, Chiang Mai, Thailand, and Their Potential for Use as Osteoprotective Products.

Authors:  Treethip Sukkho; Chartchai Khanongnuch; Saisamorn Lumyong; Jetsada Ruangsuriya; Thanawat Pattananandecha; Sutasinee Apichai; Fumihiko Ogata; Naohito Kawasaki; Chalermpong Saenjum
Journal:  Plants (Basel)       Date:  2022-06-01

2.  Antibacterial Activity against Foodborne Pathogens and Inhibitory Effect on Anti-Inflammatory Mediators' Production of Brazilin-Enriched Extract from Caesalpinia sappan Linn.

Authors:  Thanawat Pattananandecha; Sutasinee Apichai; Jakaphun Julsrigival; Fumihiko Ogata; Naohito Kawasaki; Chalermpong Saenjum
Journal:  Plants (Basel)       Date:  2022-06-27

Review 3.  Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.

Authors:  Zhifu Cui; Xingtao Zhao; Felix Kwame Amevor; Xiaxia Du; Yan Wang; Diyan Li; Gang Shu; Yaofu Tian; Xiaoling Zhao
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

4.  Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis.

Authors:  Ann Yehong Huang; Zhencheng Xiong; Kuankuan Liu; Yanan Chang; Li Shu; Guolan Gao; Chi Zhang
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

5.  Rutin alleviates cardiomyocyte injury induced by high glucose through inhibiting apoptosis and endoplasmic reticulum stress.

Authors:  Jing Wang; Ru Wang; Jiali Li; Zhuhua Yao
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.